Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07135596

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction

Research on the Effectiveness and Safety of Treatment With OviTex® PRS - a Breast Reconstruction Evaluation

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
235 (estimated)
Sponsor
Tela Bio Inc · Industry
Sex
Female
Age
22 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of OviTex PRS in subjects undergoing implant-based breast reconstruction.

Conditions

Interventions

TypeNameDescription
DEVICEOviTex PRSA multi-layer construct of extracellular matrix (ECM) derived from ovine forestomach and embroidered with polymer filament.

Timeline

Start date
2026-03-01
Primary completion
2030-06-01
Completion
2034-06-01
First posted
2025-08-22
Last updated
2026-02-06

Regulatory

Source: ClinicalTrials.gov record NCT07135596. Inclusion in this directory is not an endorsement.

Effectiveness and Safety of OviTex® PRS in Breast Reconstruction (NCT07135596) · Clinical Trials Directory